European review concludes new warnings needed for Strattera

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1526, 2006-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health Canada concludes from a recent safety review that hepatotoxicity remains an important safety concern for patients using antiandrogens.

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

New warnings of renal dysfunction associated with Aclasta

Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

New warnings for gadolinium-containing contrast agents

Reactions Weekly, Vol. 1, Iss. 1319, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

US NovoSeven labelling update includes new AEs and warnings

Reactions Weekly, Vol. 1, Iss. 1081, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

No safety concerns with Rotarix concludes EMA

Reactions Weekly, Vol. 1, Iss. 1295-1296, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite